The effect of environmental factors in biofilm‑phage interactions in Agent Based Model
Blessing O. Emerenini · 2025
Read The effect of environmental factors in biofilm‑phage interactions in Agent Based Model by Blessing O. Emerenini (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2502-18507.txt.
Introduction
Blessing Emerenini and co-authors model how viruses that attack bacteria fare inside biofilms under changing conditions. Their paper appeared in 2025. Biofilms are dense bacterial cities that blunt many treatments. With antibiotic resistance rising, virus-based phage therapy is a hopeful alternative. The team built an agent-based model, where each bacterium and virus moves and acts on its own.
They varied temperature, acidity, and food supply, using a common gut bacterium as the test case. Bacteria mutated to cope with both the setting and the treatment. Timing and dose of phage and antibiotic together decided success, and biofilm shape mattered too. The authors argue that treatment plans should be tuned to the patient's state and the local environment, not given blindly.
Catalog record
| CREATOR | Blessing O. Emerenini |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 98 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2502-18507
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The effect of environmental factors in biofilm‑phage interactions in Agent Based Model Blessing O. Emerenini Abstract Abstract As antibiotic resistance continues to pose a significant threat to public health, alternative treatments are urgently needed. Phage therapy, which utilizes bacteriophages to specifically target bacterial pathogens, has emerged as a promising solution. Given that bacteria often exist in biofilms -complex micro-communities that complicate treatment strategies, there is a clear need for models that account for spatial dynamics. This study aims to employ mathematical and statistical methodologies to identify optimal treatment strategies involving phage-antibiotic combinations. We developed an agent-based model to analyze how environmental factors (e.g. temperature, pH, and resource availability) influence bacteria-phage interactions during therapy, focusing on both healthy and immunocompromised patients. Utilizing Escherichia coli as a case study, we observed that bacterial cells exhibit mutations that enhance their adaptability to varying environmental conditions and treatment approaches. Our findings suggest that the effectiveness of therapies targeting pathogenic and mutated bacterial cells can be significantly improved through strategic control of application timing and dosing. Additionally, we investigated the impact of biofilm structure on the efficacy of phage therapy, underscoring its importance in developing targeted treatment strategies. Key words: Phages, Biofilm, Antibiotics, Agent based model, Corrosion, NetLogo 1 Introduction Bacterial infections are a significant cause of various diseases, resulting in millions of global human deaths each year [ 29 ] . To combat these infections, the development and prescription of new antibiotics have been prevalent over the past century. However, bacteria have evolved to become resistant to these drugs through genetic mutation and natural selection, leading to a decline in the effectiveness of many standard-of-care antibiotics [ 13 , 31 ] . Antibiotic resistance has been recognized as a global public health crisis by leaders in the field, posing a threat to our ability to combat diseases effectively [ 36 , 44 ] . It is estimated that antimicrobial resistance caused around 4.95 million deaths globally in 2019, with approximately 1.27 million of these deaths attributed to antibacterial resistance [ 42 ] . In the United States alone, antibiotic resistance leads to more than 2.8 million infections and over 35,000 deaths annually [ 4 ] . Additionally, the use of antibiotics can harm both infection-causing and beneficial bacteria, necessitating the exploration of alternative methods to combat bacterial infections [ 45 , 40 , 38 ] . One such alternative treatment involves bacteriophages commonly referred to as phages, which are viruses that infect bacteria and utilize their metabolism to produce more phage copies, ultimately leading to the death of the infected bacterial cell [ 23 ] . Phage therapy, which utilizes these phages to target bacterial infections in humans, has garnered attention as a potential solution due to its specificity and ability to self-multiply at the site of infection, minimizing collateral damage [ 47 ] . Moreover, phages are abundant in nature, making them readily available for medical use. With the increasing concerns about antibiotic resistance, phage therapy has gained renewed interest as a potential alternative or supplement to antibiotic treatments. Bacteria most commonly occur in biofilms, biological structures which attach to a surface and offer protection from antimicrobial agents or harsh environments [ 47 ] . When a biofilm continues to gain more area, it becomes more difficult for an antimicrobial to eradicate it from an infected organism. Within the biofilms, the typically pathogenic bacterial cells become attached, or sessile, to their surface and create extracellular polymeric substances, also referred to as EPSs, which shield the pathogens from antibiotics or other antimicrobials. While the study of bacterial infections has a history dating back thousands of years, biofilms have only been explored since the 17th century [ 5 ] . The human immune system, particularly innate immunity, plays a crucial role in eradicating bacterial infections and biofilms [ 35 ] . Innate immunity provides a faster and more general response to pathogens compared to adaptive immunity, which is slower and more targeted. Understanding the interactions between antibiotics, phages, immunity, and pathogenic bacteria is essential for comparing treatment strategies effectively [ 35 ] . In this study, we aimed to create a model that simulates the behaviors of antibiotics, phages, and bacteria while using biologically motivated values for their movements and functions. The objective was to explore various environments and their effects on pathogenic growth rates to determine effective treatment strategies. Although both innate and adaptive immunity are vital in eliminating pathogens, we focused on short-term infection dynamics in this study and did not consider the impact of the adaptive immune system. Various modeling approaches have been utilized to explore interactions between antibiotics, phages, and bacteria. For the current study, both qualitative and quantitative results are essential. While ordinary differential equation (ODE) models are commonly used in computational biology, they are limited to single independent variables, making them unsuitable for considering multiple independent variables in multiple species [ 16 ] . Partial differential equation (PDE) models, while useful for physical problems, lack the clarity needed for our model’s physical parameters. Consequently, we opted for Agent-Based Modeling (ABM) to simulate interactions between different species with distinct properties, accounting for spatial effects and individual-level changes within the population [ 27 , 11 ] . ABM is a stochastic modeling system that employs a bottom-up approach, where population-level behaviors emerge from individual entities rather than the other way around [ 11 ] . ABM has been successfully applied to study bacterial and biofilm growth dynamics, as well as the effects of antibiotics and phage treatments [ 41 , 26 , 17 , 32 ] . Incorporating immunity and other human effects, our ABM model extends current research on phage therapy. Despite the limitations of Agent-Based Models, such as the need to interpret data for numerous agents at each time step, the impact is negligible for the scope of this study, which solely aims to observe short-term behaviors within a confined space. Throughout this article, we will present the parameters, numerical formulations, and simulations used in our model. We will discuss the assumptions made and then present the data from our simulations involving antibiotics, phages, and their combined treatments in both free-floating and biofilm settings. We will also explore the impact of environmental conditions on each treatment. Finally, we will interpret the results in the context of biology and medicine, determine the most effective treatment strategy based on performance metrics, and compare the outcomes of our three simulations. 2 Methods and Model Formulation 2.1 Model Basics and Parameters We developed an agent-based model in the NetLogo program that accounts for the numerous factors at play in the growth of infectious bacteria in human or in vitro settings. NetLogo is a programming language and environment developed in 1999 and based on the Logo language [ 58 ] . It features an interface that includes a 2- or 3- dimensional display of the “world” in which the simulation plays out, optional plots and monitors for outputs, and buttons and other interactive elements to build an easy-to-operate front-end. The model updates in discrete timesteps called ticks. The world consists of a grid of square regions, called patches, with individual properties. Agents are created and given individual properties, move in specified patterns, and interact